Clinical Trial Update: VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS) [NA]

View source ↗

Summary

The VITALYST Early Feasibility Study in high-risk Percutaneous Coronary Intervention has completed; the update confirms the Boston Scientific-sponsored study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Snippet

Sponsor: Boston Scientific Corporation | Conditions: High-risk Percutaneous Coronary Intervention, Heart Disease, Coronary | NA | Status: COMPLETED